Vitamin D status in patients with frontal fibrosing alopecia: A retrospective study
Authors: lexis Arasu, MBBS (hons), BMedSc (hons), Nekma Meah, MBChB, MRCP (UK), MRCP (Derm) Samantha Eisman, MBChB, MRCP (UK), Dmitri Wall, MB BCh, MRCP, Rodney Sinclair, MBBS, MD
Below is a summary of the research study and conclusion in simple terms. For readers with academic or medical interest please see the full study.
Frontal fibrosing alopecia (FFA) is characterized by the recession of the frontal hair line. The condition is complex and dependent on a number of factors, with hormonal, environmental, and genetic factors potentially involved.
Previous research has highlighted the capability of vitamin D to alter the immune response. As a result, facial sunscreen products have been suggested as possible contributors to FFA. Avoidance is recommended by some hair specialists as part of treatment.
The research study aimed to assess the baseline levels of vitamin D in a cohort of patients with FFA.
Read the full research study here: Frontal Fibrosing Alopecia and Vitamin D
Research findings suggest that there may be no additional requirement to measure vitamin D levels in patients with FFA compared to other forms of alopecia
Vitamin D deficiency is unlikely to be a factor in the causes FFA.
The findings neither supports nor disproves an association between the application of facial sunscreen and FFA.